Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
2seventy bio (TSVT)
NASDAQ:TSVT
2seventy bio (TSVT) Stock Price & Analysis
244 Followers
TSVT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.54 - $12.69
Previous Close$4.87
Volume373.87K
Average Volume (3M)1.08M
Market Cap
$250.34M
Enterprise Value$259.88M
Total Cash (Recent Filing)$250.62M
Total Debt (Recent Filing)$260.16M
Price to Earnings (P/E)-1.1
Beta1.62
Next Earnings
Aug 07, 2024EPS Estimate
-$0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.34
Shares Outstanding51,405,419
10 Day Avg. Volume459,369
30 Day Avg. Volume1,082,037
Standard Deviation0.33
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.81
Price to Sales (P/S)4.51
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.69
Enterprise Value/Gross Profit7.89
Enterprise Value/Ebitda-1.48
Forecast
1Y Price Target
$11.50Price Target Upside130.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
2seventy bio News
PremiumCompany Announcements
2seventy bio’s Abecma Wins FDA Approval for Multiple Myeloma
PremiumCompany Announcements
2seventy bio Finalizes Asset Sale and Executive TransitionBulls Say, Bears Say
Bulls Say
Financial OutlookStrategic Realignment Is A Prudent Decision with tremendous reduction in cash burn, extending cash runway beyond 2027.
Manufacturing And SupplyThe acute supply shortage for ABECMA will likely be alleviated with the addition of manufacturing facilities.
Market ExpansionAbecma gained FDA approval for a label expansion which could lead to increased usage in earlier treatment lines for multiple myeloma.
Bears Say
Financial PerformanceAbecma's flat sales at $52mn in 1Q24 US sales indicate a challenging start to the year.
Market CompetitionAbecma is losing market share in the face of increasing competition from both Carvykti and bispecifics.
Regulatory RisksFDA’s briefing documents focused heavily on the observation of early deaths and overall benefit/risk in the context of OS data.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TSVT FAQ
What was 2seventy bio’s price range in the past 12 months?
2seventy bio lowest stock price was $1.53 and its highest was $12.69 in the past 12 months.
What is 2seventy bio’s market cap?
Currently, no data Available
When is 2seventy bio’s upcoming earnings report date?
2seventy bio’s upcoming earnings report date is Aug 07, 2024 which is in 82 days.
How were 2seventy bio’s earnings last quarter?
2seventy bio released its earnings results on May 08, 2024. The company reported -$1.01 earnings per share for the quarter, missing the consensus estimate of -$0.746 by -$0.264.
Is 2seventy bio overvalued?
According to Wall Street analysts 2seventy bio’s price is currently Undervalued.
Does 2seventy bio pay dividends?
2seventy bio does not currently pay dividends.
What is 2seventy bio’s EPS estimate?
2seventy bio’s EPS estimate is -$0.67.
How many shares outstanding does 2seventy bio have?
2seventy bio has 51,405,420 shares outstanding.
What happened to 2seventy bio’s price movement after its last earnings report?
2seventy bio reported an EPS of -$1.01 in its last earnings report, missing expectations of -$0.746. Following the earnings report the stock price went down -9.677%.
Which hedge fund is a major shareholder of 2seventy bio?
Among the largest hedge funds holding 2seventy bio’s share is Baker Bros Advisors LP. It holds 2seventy bio’s shares valued at 13M.
---
2seventy bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.50 (130.00% Upside)
$11.50 (130.00% Upside)
Blogger Sentiment
Bullish
TSVT Sentiment 75%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-58.16%
12-Months-Change
Fundamentals
Return on Equity
-73.34%
Trailing 12-Months
Asset Growth
-31.17%
Trailing 12-Months
Company Description
2seventy bio
2seventy bio Inc is primarely in the business of pharmaceutical preparations.
---
TSVT Earnings Call
Q1 2024
0:00 / 0:00
---
TSVT Stock 12 Month Forecast
Average Price Target
$11.50
▲(130.00% Upside)
Technical Analysis
Best Analysts Covering TSVT
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-44.42%
reiterated a buy rating 8 days ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -44.42% per trade.
---